OC
QDEL icon

Oppenheimer & Co’s QuidelOrtho QDEL Stock Holding History

Oppenheimer & Co’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,797
Closed -$315K – 1512
2022
Q1 		$315K Buy
2,797
+146
+6% +$15.6K 0.01% 1179
2021
Q4 		$358K Sell
2,651
-1,245
-32% -$173K 0.01% 1150
2021
Q3 		$550K Buy
3,896
+376
+11% +$50.5K 0.01% 979
2021
Q2 		$451K Sell
3,520
-2,158
-38% -$254K 0.01% 1078
2021
Q1 		$726K Buy
5,678
+1,684
+42% +$311K 0.01% 820
2020
Q4 		$718K Sell
3,994
-12,692
-76% -$2.82M 0.02% 759
2020
Q3 		$3.66M Buy
16,686
+15,501
+1,308% +$3.46M 0.09% 254
2020
Q2 		$265K Buy
+1,185
New +$186K 0.01% 1007
2015
Q3 		– Sell
-17,269
Closed -$396K – 1440
2015
Q2 		$396K Buy
17,269
+9,867
+133% +$230K 0.01% 979
2015
Q1 		$200K Sell
7,402
-21,200
-74% -$541K 0.01% 1310
2014
Q4 		$827K Buy
+28,602
New +$775K 0.02% 671

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Oppenheimer & Co's QDEL Position: Q2 2022 in Review

Oppenheimer & Co sold out of QuidelOrtho (QDEL) in Q2 2022, closing a stake of 2,797 shares — an estimated $315K sold.

Oppenheimer & Co first reported a position in QDEL in Q4 2014 and held it in 11 quarters. The position peaked at $3.66M in Q3 2020. 347 funds tracked by Wall St. Rank hold QDEL as of Q2 2022.

  • Oppenheimer & Co reported no remaining QuidelOrtho position as of Q2 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 2,797 QuidelOrtho shares in Q2 2022, an estimated $315K.
  • Oppenheimer & Co first reported a position in QuidelOrtho in Q4 2014 and held it in 11 quarters.
  • Oppenheimer & Co's QuidelOrtho position peaked at $3.66M in Q3 2020.
  • 347 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2022.

Based on Oppenheimer & Co's 13F filing for Q2 2022, filed 8 Aug 2022.